Literature DB >> 18391028

Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.

Marc H Scheetz1, Stephanie A Knechtel, Michael Malczynski, Michael J Postelnick, Chao Qi.   

Abstract

Clinical enterococcal resistance to linezolid is defined by the presence of the G2576T mutation. We evaluated the incidence of genetically proven linezolid resistance among vancomycin-resistant Enterococcus faecium strains and linezolid consumption for a possible association. A relationship was found (r(2) = 0.73, P = 0.03) and predicts increasing resistance with current trends of linezolid use.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18391028      PMCID： PMC2415807          DOI： 10.1128/AAC.00070-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.

Authors:  S H Marshall; C J Donskey; R Hutton-Thomas; R A Salata; L B Rice
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci.

Authors:  Fred C Tenover; Portia P Williams; Sheila Stocker; Angela Thompson; Leigh Ann Clark; Brandi Limbago; Roberta B Carey; Susan M Poppe; Dean Shinabarger; John E McGowan
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

3.  Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization.

Authors:  Guido Werner; Melanie Bartel; Nele Wellinghausen; Andreas Essig; Ingo Klare; Wolfgang Witte; Sven Poppert
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

4.  Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.

Authors:  Manjunath P Pai; Keith A Rodvold; Paul C Schreckenberger; Ronald D Gonzales; Jennifer M Petrolatti; John P Quinn
Journal:  Clin Infect Dis       Date:  2002-10-28       Impact factor: 9.079

5.  The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.

Authors:  Marc H Scheetz; Chao Qi; Gary A Noskin; John R Warren; Michael J Postelnick; Michael Malczynski; Jie Huang; Teresa R Zembower
Journal:  Diagn Microbiol Infect Dis       Date:  2006-08-23       Impact factor: 2.803

6.  Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.

Authors:  J Prystowsky; F Siddiqui; J Chosay; D L Shinabarger; J Millichap; L R Peterson; G A Noskin
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 7.  Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci.

Authors:  R Facklam; J A Elliott
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

8.  Response to emerging infection leading to outbreak of linezolid-resistant enterococci.

Authors:  Marion A Kainer; Rose A Devasia; Timothy F Jones; Bryan P Simmons; Kelley Melton; Susan Chow; Joyce Broyles; Kelly L Moore; Allen S Craig; William Schaffner
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

9.  Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis.

Authors:  Michael Lobritz; Rebecca Hutton-Thomas; Steve Marshall; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.

Authors:  Chao Qi; Xiaotian Zheng; Arlene Obias; Marc H Scheetz; Michael Malczynski; John R Warren
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948
View more
  17 in total

1.  Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.

Authors:  Akinori Okano; Atsushi Nakayama; Kejia Wu; Erick A Lindsey; Alex W Schammel; Yiqing Feng; Karen C Collins; Dale L Boger
Journal:  J Am Chem Soc       Date:  2015-03-09       Impact factor: 15.419

2.  Molecular analysis of linezolid resistance in clinical Enterococcus faecium isolates by polymerase chain reaction and pyrosequencing.

Authors:  P Schnitzler; K Schulz; C Lampson; M Geiss; H K Geiss
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-03       Impact factor: 3.267

3.  Discontinuation of reflex testing of stool samples for vancomycin-resistant enterococci resulted in increased prevalence.

Authors:  Mandy Bodily; Kathleen M McMullen; Anthony J Russo; Nupur D Kittur; Joan Hoppe-Bauer; David K Warren
Journal:  Infect Control Hosp Epidemiol       Date:  2013-06-27       Impact factor: 3.254

4.  Linezolid-resistant Enterococcus (LRE) faecium from Blood Culture of an Adult Burns Patient: First Report of LRE from Mumbai.

Authors:  Sujata M Baveja; Anuradha S De; Shreeraj L Talwadekar; Ravidas A Vasave
Journal:  J Glob Infect Dis       Date:  2017 Jan-Mar

5.  Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island.

Authors:  Willem van Schaik; Janetta Top; David R Riley; Jos Boekhorst; Joyce E P Vrijenhoek; Claudia M E Schapendonk; Antoni P A Hendrickx; Isaäc J Nijman; Marc J M Bonten; Hervé Tettelin; Rob J L Willems
Journal:  BMC Genomics       Date:  2010-04-14       Impact factor: 3.969

6.  Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status.

Authors:  Milena McLaughlin; Michael Malczynski; Chao Qi; Grace Barajas; Jordan Radetski; Teresa Zembower; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

7.  Genome-wide identification of ampicillin resistance determinants in Enterococcus faecium.

Authors:  Xinglin Zhang; Fernanda L Paganelli; Damien Bierschenk; Annemarie Kuipers; Marc J M Bonten; Rob J L Willems; Willem van Schaik
Journal:  PLoS Genet       Date:  2012-06-28       Impact factor: 5.917

8.  The first linezolid-resistant Enterococcus faecium in India: High level resistance in a patient with no previous antibiotic exposure.

Authors:  Simit Kumar; Maitreyi Bandyoapdhyay; Mitali Chatterjee; Prabir Mukhopadhyay; Sumon Poddar; Parthajit Banerjee
Journal:  Avicenna J Med       Date:  2014-01

9.  Use of daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections: a short case series.

Authors:  Divya Pradeep Ramaswamy; Maria Amodio-Groton; Stephen J Scholand
Journal:  BMC Urol       Date:  2013-07-16       Impact factor: 2.264

Review 10.  Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.

Authors:  Tristan O'Driscoll; Christopher W Crank
Journal:  Infect Drug Resist       Date:  2015-07-24       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.